药品安全性和有效性方面不容松懈。
No relaxation on drug safety and efficacy.
作者信息
Russell A S, Grace M
机构信息
Department of Rheumatology/Clinical Immunology, University of Alberta, Edmonton, Canada.
出版信息
World Health Forum. 1993;14(1):31-3.
PMID:8439367
Abstract
The background and current status of legislation and practice relating to drug certification in Canada are examined. An outline is given of procedures introduced to handle the growing workload faced by the regulatory authority.
摘要
本文考察了加拿大药品认证相关的立法与实践的背景及现状。概述了为应对监管机构日益增加的工作量而引入的程序。
相似文献
1
No relaxation on drug safety and efficacy.药品安全性和有效性方面不容松懈。
World Health Forum. 1993;14(1):31-3.
2
3
Drug importation and safety of drugs obtained from Canada.从加拿大进口药品及药品安全性。
Ann Pharmacother. 2007 Jul;41(7):1288-91. doi: 10.1345/aph.1K249. Epub 2007 Jun 19.
4
5
Canada's Food and Drugs Act: is it really doing the job it was set up to do?加拿大的《食品和药品法案》：它真的在履行其设立时所设定的职责吗？
Can Nurse. 1983 Feb;79(2):25-6.
6
The emerging effects of the Drug Price Competition and Patent Term Restoration Act of 1984.1984年《药品价格竞争与专利期限恢复法案》的新影响。
J Contemp Health Law Policy. 1992 Spring;8:361-78.
7
Supreme Court rules against drug patent "evergreening".最高法院做出不利于药品专利“常青化”的裁决。
CMAJ. 2006 Dec 5;175(12):1508-9. doi: 10.1503/cmaj.061513.
8
A survey of developments in food and drug law from July 1998 to November 1999.1998年7月至1999年11月食品与药品法发展情况调查。
Food Drug Law J. 2000;55(1):35-56.
9
Drug marketing exclusivity under United States and European Union law.美国和欧盟法律下的药品市场独占权。
Food Drug Law J. 2004;59(4):479-518.
10
Amendments to the Canadian Patent Act to address drug access: is help on the way?加拿大《专利法》中关于解决药品可及性问题的修正案：援助即将到来吗？
Food Drug Law J. 2005;60(3):459-70.
Zotero 插件